NCT00190762View on ClinicalTrials.gov

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

PHASE3CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

November 30, 2005

Conditions

Mesothelioma

Interventions

DRUG

Pemetrexed

Trial Locations (1)

K1H8L6

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9:00 AM - 5:00 PM Eastern Time (UTC/GMT - 5 hrs, EST), or speak with your personal physician, Ottawa

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00190762 - A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma | Biotech Hunter | Biotech Hunter